Abrdn PLC Sarepta Therapeutics, Inc. Transaction History

Abrdn PLC

$53.3 Billion
Q3 2024

A detailed history of Abrdn PLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Abrdn PLC holds 431,098 shares of SRPT stock, worth $51.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

431,098

Previous 329,845 30.7%

Holding current value

$51.3 Million

Previous $52.1 Million 3.32%

% of portfolio

0.1%

Previous 0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$124.33 - $156.75 $12.6 Million - $15.9 Million	101,253 Added 30.7%	431,098 $53.8 Million
Q2 2024 Aug 09, 2024	BUY	$113.33 - $163.85 $15.6 Million - $22.6 Million	137,988 Added 71.92%	329,845 $52.1 Million
Q1 2024 May 08, 2024	BUY	$93.7 - $141.53 $4.22 Million - $6.37 Million	45,028 Added 30.67%	191,857 $24.8 Million
Q4 2023 Jan 31, 2024	BUY	$67.31 - $124.76 $9.88 Million - $18.3 Million	146,829 New	146,829 $14.2 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $333,280 - $467,208	-5,052 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$69.38 - $86.75 $203,422 - $254,351	-2,932 Reduced 36.72%	5,052 $393,000
Q1 2021 May 06, 2021	BUY	$72.25 - $168.95 $17,195 - $40,210	238 Added 3.07%	7,984 $596,000
Q4 2020 Feb 10, 2021	BUY	$125.56 - $178.74 $26,995 - $38,429	215 Added 2.85%	7,746 $1.32 Million
Q3 2020 Oct 21, 2020	BUY	$127.12 - $172.34 $410,343 - $556,313	3,228 Added 75.02%	7,531 $1.06 Million
Q2 2020 Aug 10, 2020	SELL	$93.0 - $171.7 $6,417 - $11,847	-69 Reduced 1.58%	4,303 $690,000
Q1 2020 May 13, 2020	BUY	$82.38 - $131.64 $9,803 - $15,665	119 Added 2.8%	4,372 $428,000
Q4 2019 Feb 18, 2020	BUY	$76.53 - $135.58 $6,734 - $11,931	88 Added 2.11%	4,253 $549,000
Q3 2019 Nov 13, 2019	BUY	$72.81 - $156.91 $303,253 - $653,530	4,165 New	4,165 $314,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account